Actinium Pharma Cash Flow - Quarterly (NYSEMKT:ATNM)

Add to My Stocks
$0.74 $0.01 (1.37%) ATNM stock closing price Sep 21, 2018 (Closing)

The financial analysis of ATNM requires an investor to check the cash flows for Actinium Pharma. While its important to look at the Actinium Pharma debt position, the cash flow statement becomes equally important because public companies use accrual accounting. For example, if a company sells a product which gets counted as Actinium Pharma revenue but does not convert to cash because it does not receive payment in the same quarter, it affects the cash position for that period. Actinium Pharma stock analysis shows negative net income cash flow of $-11.19M till 2018 Q2. This statement is important because profits alone cannot pay employees, or bills. Cash is required. Actinium Pharma has a positive cash and cash equivalents change of $4.11M.

View and download details of Actinium Pharma cash flows for latest & last 40 quarters
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Net Income Cash Flow
-11.19M-6.31M-26.6M-21.43M-15.11M-8.06M-24.32M-17.62M-11.02M-4.4M
Depreciation Depletion Amortization Cash-Flow----------
Net Increase (Decrease) in Assets Liabilities--1.8M--1.37M1.68M--0.15M-
Cash From (used in) Discontinued Operations----------
Other Adjustments Net1.01M-3.18M2.58M2.27M1.28M1.76M---0.61M
Net Cash from (used by) Operating Activities
-9.67M-5.45M-21.55M-18.38M-12.51M-5.37M-20.78M-16.54M-10.97M-4.75M
Increase (Decrease) in Prop Plant And Equipment-0.03M-0.01M-0.02M-0.02M-0.01M-0.01M-0.05M-0.04M-0.04M-0.02M
Acquisition Disposition of Subsidiaires----------
Increase (Decrease) in Investments----------
Other Cash Inflow (Outflow) from Investment Activities---0.35M-0.35M-0.35M--0.04M-0.04M-0.04M-0.04M
Net Cash from (used by) Investment Activities
-0.03M-0.01M-0.38M-0.37M-0.37M--0.1M-0.09M-0.09M-0.07M
Issuance (Purchase) of Equity Shares13.81M14.87M18.81M18.78M3.82M1.91M16.04M6.79M6.05M1.48M
Issuance (Repayment) of Debt Securities-------0.26M-0.26M-0.17M-0.08M
Increase (Decrease) in Bank & Other Borrowings----------
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities----------
Net Cash from (used by) Financing Activities
13.81M14.87M18.81M18.78M3.82M1.91M15.77M6.52M5.88M1.39M
Effect of Exchange Rate Changes on Cash----------
Net Change in Cash & Cash Equivalents
4.11M9.4M-3.11M--9.06M-3.43M-5.12M-10.11M-5.18M-3.43M
Cash & Equivalents at Beginning of Year17.79M20.51M25.64M6.7M5.53M5.61M5.7M---
Cash & Equivalents at Year End21.91M27.19M17.39M20.54M11.45M17.08M20.51M15.52M20.45M22.2M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Actinium Pharma stock comparison chart provides an easy way to compare the stock price with peers along with details of Actinium Pharma stock price history.
The statement of cash flows can be categorized into the following main sections:

  • Actinium Pharma has cash of $21.91M on hand. A healthy amount of cash on hand is necessary for any company. Cash has an opportunity cost associated with it, and too much cash in bank may mean that the firm has no or limited growth plans. Hence its important to track the Net Change in Cash and Cash Equivalents along with the Actinium Pharma stock price.
  • Actinium Pharma decreased its cash from operating activities to $-9.67M till 2018 Q2. Operating activities include production of goods or creating a product or providing a service, and collecting payment for the same from customers. The cash generated from these activities is refered to as cash flow from operating activities.
  • Growth companies, typically most tech companies; spend heavily on investing activities and this figure stood at $-0.03M for ATNM stock. Sometimes a company might have a negative overall cash flow which may not be really bad if it is due to investment expenses. Hence it is important to check the cash flow from investment activities.
  • Inflow of cash in the form of bank loans and shareholders equity, and outflow of cash because of dividend payments, share repurchase payments etc. come under financing activities. The cash generated from these activities was $13.81M for Actinium Pharma.

Key Financial Ratios For Actinium Pharma Cash Flow

Quarterly Cash Flow Statements For Actinium Pharmaceuticals Inc Peers

Bio-Path cash flow, Cipher Pharma cash flow, Elite Pharma cash flow, MEDPACE HLDGS cash flow, Seattle Genetics cash flow